B

Halozyme Therapeutics, Inc. HALO

NASDAQ
Recommendation
Dividend Power Score
Day's Range
$95.01$97.96
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
My Lists My Alerts

09/30/2026 06/30/2026 03/31/2026 12/31/2025 09/30/2025
Revenue 1.80B 1.66B 1.51B 1.40B 1.24B
Total Other Revenue -- -- -- -- --
Total Revenue 1.80B 1.66B 1.51B 1.40B 1.24B
Cost of Revenue 432.55M 394.79M 351.86M 310.26M 262.09M
Gross Profit 1.37B 1.27B 1.16B 1.09B 980.76M
SG&A Expenses 236.45M 224.30M 208.91M 193.39M 172.31M
Depreciation & Amortization 111.91M 100.16M 88.41M 76.66M 71.05M
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 780.91M 719.25M 649.18M 580.32M 505.45M
Operating Income 1.02B 944.49M 859.28M 816.29M 737.40M
Income Before Tax 655.01M 583.34M 503.37M 466.88M 745.94M
Income Tax Expenses 169.59M 169.74M 154.53M 149.99M 150.45M
Earnings from Continuing Operations 485.42 413.60 348.84 316.89 595.49
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 485.42M 413.60M 348.84M 316.89M 595.49M
EBIT 1.02B 944.49M 859.28M 816.29M 737.40M
EBITDA 1.14B 1.05B 953.01M 897.84M 813.28M
EPS Basic 4.20 3.52 2.92 2.61 4.90
Normalized Basic EPS 5.41 4.98 4.51 4.28 3.81
EPS Diluted 3.93 3.35 2.78 2.49 4.75
Normalized Diluted EPS 5.21 4.84 4.40 4.19 3.70
Average Basic Shares Outstanding 466.89M 470.31M 474.38M 479.45M 488.18M
Average Diluted Shares Outstanding 484.37M 484.09M 487.04M 490.81M 502.11M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --